Results 151 to 160 of about 7,668 (229)

Combined Therapy Versus Fortified Anti-VEGF Monotherapy in Type C Polypoidal Choroidal Vasculopathy: Long-Term Outcomes and Exploratory Biomarker Insights. [PDF]

Int J Mol Sci
Chao WW, Chao HW, Chao HM.
europepmc   +1 more source

Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. [PDF]

Pharmaceuticals (Basel)
Fukuda Y, Sakurada Y, Kotoda Y, Kimura M, Kashiwagi K.   +4 more
europepmc   +1 more source

Localization of Polypoidal Choroidal Vasculopathy in Fluorescein Angiography Using Semisupervised Deep Learning With Labeled and Unlabeled Images. [PDF]

Transl Vis Sci Technol
Lin CC, Tsao YN, Lin WY, Ruamviboonsuk P, Wu TT, Chen SJ, Tsai CL.   +6 more
europepmc   +1 more source

Choroidal Venous Architecture and Polypoidal Lesion Distribution in Subtypes of Polypoidal Choroidal Vasculopathy Using Widefield Imaging. [PDF]

Transl Vis Sci Technol
Zhang Y, Li M, He G, Gan Y, Zhuang X, Chen X, Pu J, Su Y, Hao X, Wen F.   +9 more
europepmc   +1 more source

Full-Thickness Macular Hole Formation After Intravitreal Faricimab Injection for Polypoidal Choroidal Vasculopathy. [PDF]

Int Med Case Rep J
Tavonvunchai F, Chanwimol K.
europepmc   +1 more source

Polypoidal Choroidal Vasculopathy: From Clinicopathological and Molecular Perspectives.

Ophthalmic Res
Zhang C, Zhang W, Wang T, Wen L, Zhang J.   +4 more
europepmc   +1 more source

Age-Related Scattered Hypofluorescent Spots as an Adverse Prognostic Factor for Polypoidal Choroidal Vasculopathy. [PDF]

Ophthalmol Sci
Kim SH, Ong KT, Choi S, Chung EJ, Kim M, Lee CS, Yeo J, Choi EY.   +7 more
europepmc   +1 more source

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.

JAMA Ophthalmol
Lee WK, Wong TY, Chen SJ, Sun X, Cheung CMG, Silva R, Ricci F, Zhang X, Machewitz T, Schulze A, Schmidt-Ott UM, Zhao M, Hasanbasic Z, Leal S, Iida T, PULSAR Study Investigators.   +15 more
europepmc   +1 more source

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases - The FAR-PEARL Study Report 1. [PDF]

Clin Ophthalmol
Fong KCS, Wong WJJ, Wong HS, Ling KP, Fong SN, Shunmugam M.   +5 more
europepmc   +1 more source

Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study. [PDF]

Eye Vis (Lond)
Wang TI, Qu J, Tang R, Shi X, Ying X, Tao Y, Li X.   +6 more
europepmc   +1 more source